| Medical Mutual | Asparlas® (calaspargase pegol-mknl) (Intravenous) (EOV) | 2025-11-01 |
| Medical Mutual | Blincyto® (blinatumomab) (Intravenous) (EOV) | 2025-11-01 |
| Medical Mutual | Gazyva® (obinutuzumab) (Intravenous) (EOV) | 2025-11-01 |
| Medical Mutual | Kadcyla® (ado-trastuzumab emtansine) (Intravenous) (EOV) | 2025-11-01 |
| Medical Mutual | Kymriah® (tisagenlecleucel) (Intravenous) (EOV) | 2025-11-01 |
| Medical Mutual | Pemetrexed: Alimta® (Intravenous) (EOV) | 2025-11-01 |
| Medical Mutual | Rylaze® (asparaginase Erwinia chrysanthemi (recombinant)-rywn) (EOV) | 2025-11-01 |
| Medical Mutual | Yescarta® (axicabtagene ciloleucel) (Intravenous) (EOV) | 2025-11-01 |
| Paramount Healthcare | Prostate Cancer Screening | 2025-11-01 |
| Paramount Healthcare | Tests for the Evaluation of Preterm Labor and
Premature Rupture of Membranes | 2025-11-01 |